35.71 8.32% 37.03 7.61% 32.61 8.83% 4.41 13.53 Profit sharing Attributed to the shareholders of the Company 29.62 6.90% 30.76 6.32% 27.95 7.56% 2.81 10.07 Attributed to the stakeholders with non
decreased 53% to THB 381m in Q3 2019 from THB 815m in Q3 2018. Net Profit decreased 55% to THB 407m in Q319 from THB 905m in Q318, due to lower operating profits in Q319 vs Q318. Quarter Quarter % THB '000
Profits increased 191% to THB 483m in Q1 2020 from THB 166m in Q1 2019. Net Profit decreased 33% to THB 204m in Q120 from THB 303m in Q119, due to a THB281m loss incurred on our hedging positions. Quarter
to mid-single digit decline. EBITDA (pre- TFRS16) stood at Bt76,619mn, decreased –2. 7% YoY with focusing on cost control and in- line with low single digit decline EBITDA guidance. Net profit ( pre
Revenues fro purchased ac nterest incom Total Revenu Cost of servic Gross Profit Discussion and /009 Manag Presid Stock to JMT Ne to certify th es for the s any’s audito of Performa rmance of t olidated fina
finance costs due to the adoption of TFRS16 • Total assets as of 31 March 2020 stood at THB 66,192mn, increasing by 23.7% or THB 12,661mn from 31 December 2019. Assets increased primarily from impact of the
additionally purchased assets from business of a dialysis unit which is business expansion as a plan laid down. And Medical Vision Co., Ltd. has distributed medical equipment. In the 1st quarter , it recognized
to 28% 2016 2017 % change million Baht million Baht y-on-y Sales and service income 27,747 31,482 13.5% EBITDA 7,494 8,725 16.4% Net profit 2,316 3,594 55.2% Normalized net profit (NNP)* 2,090 2,918
statement for Year 2020 ended as of December 31, 2020, (1 January – 31 December), which details are as following Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net profit of 488.52
growing revenue to THB 11,223 million with the Normalized Net Profit (NNP) of THB 1,158 million and NNP-owner of the parent of THB 682 million, growing 54.0% y-on-y. This remarkable performance came from 1